Envoy Medical Achieves 12-Month Milestone in Cochlear Implant Trial, PMA Submission on Track

Envoy Medical announces that the first three patients in its pivotal clinical trial for the fully implanted Acclaim cochlear implant have reached the 12-month endpoint, a key milestone in the study's progress. The company remains on schedule for a Premarket Approval submission to the FDA. The Acclaim cochlear implant is a first-of-its-kind device designed to address severe to profound sensorineural hearing loss without externally worn components.